Sepsis Diagnostics Market to Reach $2.0 Billion by 2035

Sepsis Diagnostics Market was valued at $958.5 million in 2025 and is projected to reach $2021.1 million by 2035, growing at a CAGR of 7.8% during the forecast period. Increasing incidence of hospital-acquired infections, rising antimicrobial resistance (AMR), and growing demand for rapid diagnostic technologies are major factors supporting market expansion globally.

Browse the full report description of “Sepsis Diagnostics Market Size, Share & Trends Analysis Report, By Product Type (Instruments, Consumables & Reagents, Software & Services), By Technology (Microbiology-Based Diagnostics, Molecular Diagnostics, Immunoassays, Biomarker-Based Testing), By End User (Hospitals & ICUs, Diagnostic Laboratories, Research & Academic Institutes), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/sepsis-diagnostics-market

According to the World Health Organization (WHO), sepsis affects nearly 49 million people annually worldwide and accounts for around 11 million deaths each year, representing a major global healthcare burden. WHO also states that early diagnosis and timely intervention are among the most critical factors in reducing sepsis mortality. Increasing ICU admissions and rising prevalence of bloodstream infections are accelerating the adoption of molecular diagnostics, automated blood culture systems, and biomarker-based testing solutions across hospitals and diagnostic laboratories.

Among product categories, Consumables & Reagents is projected to be the fastest-growing segment due to recurring usage of assay kits, blood culture bottles, PCR reagents, and biomarker cartridges in continuous diagnostic workflows. By technology, Molecular Diagnostics is expected to witness significant growth owing to faster pathogen identification capabilities, high diagnostic accuracy, and increasing integration of multiplex PCR platforms in critical care settings.

Key leaders transforming the sepsis diagnostics market

• In March 2025, bioMérieux announced strong 2024 financial results with total sales reaching €3.98 billion, driven by double-digit growth in BIOFIRE® molecular diagnostics and microbiology segments. The company accelerated SPOTFIRE® deployment with 3,000 installed instruments worldwide and continued expanding its infectious disease diagnostic capabilities, strengthening its position in the global sepsis diagnostics market.
• In April 2026, Cepheid and Oxford Nanopore Technologies expanded their partnership to advance rapid genomic workflows for bloodstream infection and sepsis research. The phase two collaboration focuses on rapid bacterial and fungal pathogen identification, antimicrobial resistance profiling, and genomic antibiotic susceptibility testing using positive blood cultures and culture isolates, supporting faster and more accurate sepsis diagnostics.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Technology
  • By End-User
• Competitive Landscape- F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., bioMérieux SA, Danaher Corporation, Becton, Dickinson and Company, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Sepsis Diagnostics Market Report Segment

By Product Type

• Instruments
• Consumables & Reagents
• Software & Services

By Technology

• Microbiology-Based Diagnostics
• Molecular Diagnostics
• Immunoassays
• Biomarker-Based Testing

By End User

• Hospitals & ICUs
• Diagnostic Laboratories
• Research & Academic Institutes

Global Sepsis Diagnostics Market Report Segment by Region

 North America

• United States
• Canada

 Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/sepsis-diagnostics-market